CERENOVUS, a part of Johnson & Johnson, is reporting that its EMBOTRAP II clot retriever has been used commercially for the first time in the U.S. to reverse an ischemic stroke.
The catheter-delivered device is able to securely grab onto the clot without squeezing it too hard, allowing the physician to manipulate the thrombus as a whole. This (Read more...)